Attached files

file filename
EX-31.1 - CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT OF 2002 - Cyclo Therapeutics, Inc.f10k2010ex31i_ctd.htm
EX-21.1 - SUBSIDIARIES OF CTD HOLDINGS, INC. - Cyclo Therapeutics, Inc.f10k2010ex21i_ctd.htm
10-K - ANNUAL REPORT - Cyclo Therapeutics, Inc.f10k2010_ctd.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Form 10-K of CTD Holdings, Inc. (the “Company”) for the fiscal year ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 30, 2010
By:
/s/ C.E. Rick Strattan
 
   
C.E. Rick Strattan
 
   
Chief Executive Officer
 
   
(principal executive, financial and accounting officer)